AstraZeneca has launched the Helix Project in South Africa, an initiative aimed at expanding access to advanced diagnostic testing for eligible ovarian cancer patients and...
A new immunotherapy has been registered in South Africa for the treatment of recurrent or metastatic nasopharyngeal carcinoma (RM-NPC), a rare and aggressive form of...